MedTrace Logo

A Study to Evaluate BioMarkers in Blood Samples in Subjects With Rheumatoid Arthritis

NCT01209585 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 23

Last updated 2013-07-25

No results posted yet for this study

Summary

The purpose of this study is to study the evaluation of blood samples and blood types to identify functional protein in the joints.

Conditions

Interventions

OTHER

Blood samples

Subjects will have visits on Days 1, 30 and 120.

OTHER

Synovial fluid aspiration

Subjects will have visits on Days 1, 30, and 120.

OTHER

Synovial tissue sample

Subjects will have visits on Days 1, 30, and 120.

Sponsors & Collaborators

  • AstraZeneca

    collaborator INDUSTRY

  • MedImmune LLC

    lead INDUSTRY

Principal Investigators

  • Warren Greth, MD · MedImmune LLC

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2012-11-30
Completion
2013-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01209585 on ClinicalTrials.gov